Company Filing History:
Years Active: 2010
Title: Balasingham Radhakrishnan: Innovator in Natriuretic Compounds
Introduction
Balasingham Radhakrishnan is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biochemistry, particularly in the development of modified natriuretic compounds. His work focuses on creating innovative treatments for heart conditions, especially congestive heart failure.
Latest Patents
Radhakrishnan holds a patent for "Natriuretic compounds, conjugates, and uses thereof." This invention discloses modified natriuretic compounds and their conjugated forms, which include at least one modifying moiety. These modified compounds retain their ability to stimulate cGMP production and bind to the NPR-A receptor. Additionally, they exhibit an improved half-life in circulation compared to their unmodified counterparts. The patent outlines various forms of administration, including oral, parenteral, enteral, subcutaneous, pulmonary, and intravenous methods, aimed at treating heart conditions.
Career Highlights
Throughout his career, Balasingham Radhakrishnan has worked with prominent companies in the biotechnology sector. He has been associated with Biocon Limited and Cidara Therapeutics, Inc., where he has contributed to advancing medical research and product development.
Collaborations
Radhakrishnan has collaborated with notable professionals in his field, including Kenneth D James and Navdeep Balkrishna Malkar. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Balasingham Radhakrishnan's work in developing modified natriuretic compounds represents a significant advancement in the treatment of heart conditions. His innovative approach and dedication to research continue to impact the field positively.